Enlivex
Reut Davidzon Englender has work experience in both Enlivex Therapeutics and Rozenman Travel Ltd. At Enlivex Therapeutics, they started as a Quality Control Analyst in January 2021 and held this role until March 2022. From March 2022 to March 2023, they served as a Principal Quality Control Analyst. Currently, they are working as a Quality Control Team Lead, starting in March 2023. Prior to their time at Enlivex Therapeutics, Reut worked at Rozenman Travel Ltd. as a Product Manager for the "Tenerife" product from an unspecified start year to 2017.
Reut Davidzon Englender earned a Bachelor of Science degree in Biotechnology Engineering from Ben-Gurion University of the Negev, which they attended from 2016 to 2020. Reut also obtained additional certifications in Programming Foundations: Databases, Programming Foundations: Fundamentals, and MATLAB Onramp from LinkedIn and Math in 2020.
This person is not in any teams
This person is not in any offices
Enlivex
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, Enlivex intends to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.